 ANDOVER, Mass., July 29, 2021 PRNewswire -- TransMedics Group, Inc. TransMedics Nasdaq: TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced U.S. Food and Drug Administration FDA 510k clearance of its OCSTM Lung Solution for use in transplants using cold storage techniques. 